Hayashi Y, Tsukada M, Shinoda D, et al. Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis. J Hematol. Published online January 25, 2025. doi:10.14740/jh2010